As a board-certified cardiovascular surgeon specializing in venous and lymphatic disease, I firmly believe that the introduction of micronized purified flavonoid fraction (MPFF) into the U.S. market represents perhaps the most important innovation in daily practice we’ve seen in the last 10 years.
By John Chubak, MD, FACS
















